Join this free webinar as part of your EFLM Academy membership.
LEARNING OBJECTIVES
- The specificity of molecular changes in the development and progression of malignant disease
- The use of cell-free nucleic acids in bodily fluids for early diagnosis of cancer
- The use of ctDNA monitoring for testing tumor resistance to therapy and improved clinical decision-making
- Can ctDNA be a reliable topological information?
Speaker: Michael Neumaier (Mannheim, Germany ) - Dept of Clinical Chemistry, University of Heidelberg and Institute for Clinical Chemistry, Mannheim, Germany